We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+3.26%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$2.33B
AUM Growth
+$66.7M
Cap. Flow
+$10.5M
Cap. Flow %
0.45%
Top 10 Hldgs %
23.1%
Holding
480
New
25
Increased
142
Reduced
163
Closed
10

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$2.72M
2
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$1.58M
3
PEP icon
PepsiCo
PEP
+$1.46M
4
CELG
Celgene Corp
CELG
+$1.2M
5
TDC icon
Teradata
TDC
+$1.09M

Sector Composition

Rank Sector Weight
1 Healthcare 17.01%
2 Technology 11.79%
3 Industrials 11.62%
4 Financials 11.2%
5 Consumer Staples 10.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KSU
51
DELISTED
Kansas City Southern
KSU
$14M 0.6%
115,022
-1,494
-1% -$179K
PM icon
52
Philip Morris
PM
$301B
$13.8M 0.59%
169,076
+536
+0.3% +$46K
COST icon
53
Costco
COST
$415B
$13.5M 0.58%
94,987
-1,794
-2% -$244K
ZTS icon
54
Zoetis
ZTS
$31.6B
$13.3M 0.57%
309,015
-2,652
-0.9% -$108K
C icon
55
Citigroup
C
$222B
$13.2M 0.57%
244,094
+26,028
+12% +$1.38M
MKC icon
56
McCormick & Company Non-Voting
MKC
$13.4B
$12.7M 0.55%
343,182
+4
+0% +$143
LMT icon
57
Lockheed Martin
LMT
$134B
$12.5M 0.54%
65,160
-603
-0.9% -$112K
CL icon
58
Colgate-Palmolive
CL
$72.6B
$12.5M 0.54%
180,838
-1,021
-0.6% -$69K
TFC icon
59
Truist Financial
TFC
$63.2B
$12.1M 0.52%
311,596
-2,608
-0.8% -$98.2K
EEM icon
60
iShares MSCI Emerging Markets ETF
EEM
$28B
$12M 0.52%
306,645
-20,786
-6% -$845K
VWO icon
61
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$12M 0.51%
299,677
-38,498
-11% -$1.58M
ALL icon
62
Allstate
ALL
$66.9B
$12M 0.51%
170,601
+3,593
+2% +$236K
EFA icon
63
iShares MSCI EAFE ETF
EFA
$76.4B
$11.8M 0.5%
193,324
-14,042
-7% -$877K
TEVA icon
64
Teva Pharmaceuticals
TEVA
$35.9B
$11.7M 0.5%
202,689
-3,213
-2% -$179K
EMR icon
65
Emerson Electric
EMR
$82.9B
$11.5M 0.49%
186,449
-5,757
-3% -$361K
MDY icon
66
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$10.9M 0.47%
41,334
+1,671
+4% +$428K
NTRS icon
67
Northern Trust
NTRS
$22.2B
$10.7M 0.46%
159,082
-98
-0.1% -$6.52K
KMB icon
68
Kimberly-Clark
KMB
$36.4B
$10.5M 0.45%
90,637
-4,357
-5% -$483K
TRV icon
69
Travelers Companies
TRV
$80.8B
$9.65M 0.41%
91,196
+133
+0.1% +$13.4K
WBA
70
DELISTED
Walgreens Boots Alliance
WBA
$9.6M 0.41%
125,979
-802
-0.6% -$53.6K
DE icon
71
Deere & Co
DE
$170B
$9.55M 0.41%
107,927
-624
-0.6% -$53.9K
IWR icon
72
iShares Russell Mid-Cap ETF
IWR
$56.8B
$9.44M 0.41%
226,028
+2,100
+0.9% +$85.3K
GWW icon
73
W.W. Grainger
GWW
$65.3B
$9.41M 0.4%
36,924
+900
+2% +$222K
T icon
74
AT&T
T
$165B
$9.4M 0.4%
370,539
-4,545
-1% -$118K
MDLZ icon
75
Mondelez International
MDLZ
$77.7B
$9.21M 0.4%
253,665
+3,789
+2% +$138K

Similar funds

Gofen & Glossberg's Q4 2014 Portfolio in Review

As of Q4 2014, Gofen & Glossberg held 480 positions worth $2.33B, up 2.9% from $2.26B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Gofen & Glossberg's Q4 2014 filing shows 25 new, 142 increased, 163 reduced and 10 closed positions. Its largest new stake was Vanguard FTSE Developed Markets ETF: 15,650 shares worth $593K. The largest sale was IBM, an estimated $2.72M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

  • Gofen & Glossberg's largest Q4 2014 buy was Vanguard FTSE Developed Markets ETF: 15,650 shares worth $593K.
  • Gofen & Glossberg added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $9.11M increase.
  • Gofen & Glossberg's biggest Q4 2014 reduction was IBM, cutting an estimated $2.72M.
  • Gofen & Glossberg fully exited KINDER MORGAN ENER PNTRS L.P. in Q4 2014, selling an estimated $418K.
  • Gofen & Glossberg's ten largest holdings make up 23% of its $2.33B portfolio in Q4 2014.
  • Gofen & Glossberg opened 25 new positions and closed 10 in Q4 2014.
  • Gofen & Glossberg's portfolio value rose 2.9% quarter-over-quarter to $2.33B.

Based on Gofen & Glossberg's 13F filing for Q4 2014, filed 9 Feb 2015.